RT Journal Article
SR Electronic
T1 Analysis of the learning curve for Retzius-sparing Robot-assisted radical prostatectomy for a single surgeon
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.16.23290058
DO 10.1101/2023.05.16.23290058
A1 Hussein, H
A1 Maitra, N
A1 Tay, J
A1 Saxionis, I
A1 Makin, R
A1 Sivathasan, S
A1 Smart, S
A1 Warren, A
A1 Shah, N
A1 Lamb, BW
YR 2023
UL http://medrxiv.org/content/early/2023/05/17/2023.05.16.23290058.abstract
AB Introduction The learning curve for retzius sparing robotic radical prostatectomy is not fully understood. This study attempts to identify the learning-curve across the first 130 cases of a single surgeon.Methods All retzius sparing robotic radical prostatectomy cases performed by a single surgeon between April 2019 and July 2022 were included. Cases were divided chronologically into 3 groups.Results 130 RS-RARP cases were identified. Statistically significant differences were found between groups in several areas. Median patient age increased between group 1 (59yrs) and Group 3 (66.5yrs) (P=0.04). Proportion of patients with stage >T2 increased between Group 1 (27.9%) and Group 2 (41.9%) (P=0.036). Median console time increased between Group 1 (120 mins) and Group 2 (150 mins,) (P=0.01). Median gland weight increased between Group 1 (28g) and Group 3 (35.5g) (P<0.001). Positive surgical margin rate fell between Group 1 (30.2%) and Group 3 (9.1%).Conclusions The complexity of cases increased over the learning curve, reflected in older patients, larger prostates and higher stage disease, but the positive surgical margin rate improved with experience. Safety and functional outcomes are excellent throughout. The learning curve might be facilitated by careful case selection favouring smaller prostates with less advanced disease.Competing Interest Statementall authors confirm they have no conflict of interest that are relevant to the content of this articleFunding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Cambridge University Hospitals NHS Foundation Trust waived ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors